|
[1]
|
Dragovich, M.A.and Mor, A. (2018) The SLAM Family Receptors: Potential Therapeutic Targets for Inflammatory and Autoimmune Diseases. Autoimmunity Reviews, 17, 674-682. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Calpe, S., Wang, N., Romero, X., Berger, S.B., Lanyi, A., Engel, P., et al. (2008) The SLAM and SAP Gene Families Control Innate and Adaptive Immune Responses. Advances in Immunology, 97, 177-250. https://linkinghub.elsevier.com/retrieve/pii/S0065277608000047 [Google Scholar] [CrossRef]
|
|
[3]
|
Cannons, J.L., Tangye, S.G. and Schwartzberg, P.L. (2011) SLAM Family Receptors and SAP Adaptors in Immunity. Annual Review of Immunology, 29, 665-705. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Thorley-Lawson, D.A., Schooley, R.T., Bhan, A.K. and Nadler, L.M. (1982) Epstein-Barr Virus Superinduces a New Human B Cell Differentiation Antigen (B-LAST 1) Expressed on Transformed Lymphoblasts. Cell, 30, 415-425. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Staunton, D.E., Fisher, R.C., LeBeau, M.M., Lawrence, J.B., Barton, D.E., Francke, U., et al. (1989) Blast-1 Possesses a Glycosyl-Phosphatidylinositol (GPI) Membrane Anchor, Is Related to LFA-3 and OX-45, and Maps to Chromosome 1q21-23. Journal of Experimental Medicine, 169, 1087-1099. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
McArdel, S.L., Terhorst, C. and Sharpe, A.H. (2016) Roles of CD48 in Regulating Immunity and Tolerance. Clinical immunology (Orlando, Fla.), 164, 10-20. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Smith, G.M., Biggs, J., Norris, B., Anderson-Stewart, P. and Ward, R. (1997) Detection of a Soluble Form of the Leukocyte Surface Antigen CD48 in Plasma and Its Elevation in Patients with Lymphoid Leukemias and Arthritis. Journal of Clinical Immunology, 17, 502-509. [Google Scholar] [CrossRef]
|
|
[8]
|
Metz, C.N., Brunner, G., Choi-Muira, N.H., Nguyen, H., Gabrilove, J., Caras, I.W., et al. (1994) Release of GPI-Anchored Membrane Proteins by a Cell-Associated GPI-Specific Phospholipase D. The EMBO Journal, 13, 1741-1751. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Elishmereni, M., Fyhrquist, N., Singh Gangwar, R., Lehtimäki, S., Alenius, H. and Levi-Schaffer, F. (2014) Complex 2B4 Regulation of Mast Cells and Eosinophils in Murine Allergic Inflammation. Journal of Investigative Dermatology, 134, 2928-2937. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Munitz, A., Bachelet, I., Finkelman, F.D., Rothenberg, M.E. and Levi-Schaffer, F. (2007) CD48 Is Critically Involved in Allergic Eosinophilic Airway Inflammation. American Journal of Respiratory and Critical Care Medicine, 175, 911-918. [Google Scholar] [CrossRef]
|
|
[11]
|
Gangwar, R.S., Minai-Fleminger, Y., Seaf, M., Gutgold, A., Shikotra, A., Barber, C., et al. (2017) CD48 on Blood Leukocytes and in Serum of Asthma Patients Varies with Severity. Allergy, 72, 888-895. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Tissot, C., Rebouissou, C., Klein, B. and Mechti, N. (1997) Both Human α/β and γ Interferons Upregulate the Expression of CD48 Cell Surface Molecules. Journal of Interferon & Cytokine Research, 17, 17-26. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Pahima, H., Zaffran, I., Ben-Chetrit, E., Jarjoui, A, Gaur, P., Manca, M.L., et al. (2022) COVID-19 Patients Are Characterized by Dysregulated Levels of Membrane and Soluble CD48. Annals of Allergy, Asthma & Immunology, 208, Article 161.04. [Google Scholar] [CrossRef]
|
|
[14]
|
Wu, Y., Kuang, D.M., Pan, W.D., Wan, Y.L., Lao, X.M., Wang, D., et al. (2013) Monocyte/Macrophage-Elicited Natural Killer Cell Dysfunction in Hepatocellular Carcinoma Is Mediated by CD48/2B4 Interactions. Hepatology, 57, 1107-1116. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Hosen, N., Ichihara, H., Mugitani, A., Aoyama, Y., Fukuda, Y., Kishida, S., et al. (2012) CD48 as a Novel Molecular Target for Antibody Therapy in Multiple Myeloma. British Journal of Haematology, 156, 213-224. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Chiba, M., Shimono, J., Ishio, T., Takei, N., kasahara, K., Ogasawara, R., et al. (2022) Genome-Wide CRISPR Screens Identify CD48 Defining Susceptibility to NK Cytotoxicity in Peripheral T-Cell Lymphomas. Blood, 140, 1951-1963. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Mardomi, A., Mohammadi, N., Khosroshahi, H.T. and Abediankenari, S. (2020) An Update on Potentials and Promises of T Cell Co-Signaling Molecules in Transplantation. Journal of Cellular Physiology, 235, 4183-4197. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Dong, Z., Cruz-Munoz, M.E., Zhong, M.C., Chen, R., Latour, S. and Veillette, A. (2009) Essential Function for SAP Family Adaptors in the Surveillance of Hematopoietic Cells by Natural Killer Cells. Nature Immunology, 10, 973-980. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Claus, M., Urlaub, D., Fasbender, F. and Watzl, C. (2019) SLAM Family Receptors in Natural Killer Cells-Mediators of Adhesion, Activation and Inhibition via cis and Trans Interactions. Clinical Immunology, 204, 37-42. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Nichols, K.E., Harkin, D.P., Levitz, S., Krainer, M., Kolquist, K.A., Genovese, C., et al. (1998) Inactivating Mutations in an SH2 Domain-Encoding Gene in X-Linked Lymphoproliferative Syndrome. Proceedings of the National Academy of Sciences of the United States of America, 95, 13765-13770. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Pahima, H., Puzzovio, P.G. and Levi-Schaffer, F. (2019) 2B4 and CD48: A Powerful Couple of the Immune System. Clinical Immunology, 204, 64-68. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Taniguchi, R.T., Guzior, D. and Kumar, V. (2007) 2B4 Inhibits NK-Cell Fratricide. Blood, 110, 2020-2023. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Mathew, S.O., Kumaresan, P.R., Lee, J.K., Huynh, V.T. and Mathew, P.A. (2005) Mutational Analysis of the Human 2B4 (CD244)/CD48 Interaction: Lys 68 and Glu 70 in the V Domain of 2B4 Are Critical for CD48 Binding and Functional Activation of NK Cells. The Journal of Immunology, 175, 1005-1013. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Claus, M., Wingert, S. and Watzl, C. (2016) Modulation of Natural Killer Cell Functions by Interactions between 2B4 and CD48 in cis and in Trans. Open Biology, 6, Article 160010. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Tufa, D.M., Yingst, A.M., Trahan, G.D., Shank, T., Jones, D., Shim, S., et al. (2020) Human Innate Lymphoid Cell Precursors Express CD48 That Modulates ILC Differentiation through 2B4 Signaling. Science Immunology, 5, eaay4218. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Assarsson, E., Kambayashi, T., Schatzle, J.D., Cramer, S.O., von Bonin, A., Jensen, P.E., et al. (2004) NK Cells Stimulate Proliferation of T and NK Cells through 2B4/CD48 Interactions. The Journal of Immunology, 173, 174-180. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Lee, K.M., Bhawan, S., Majima, T., Wei, H., Nishimura, M.I., Yagita, H., et al. (2003) Cutting Edge: The NK Cell Receptor 2B4 Augments Antigen-Specific T Cell Cytotoxicity through CD48 Ligation on Neighboring T Cells. The Journal of Immunology, 170, 4881-4885. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Kis-Toth, K. and Tsokos, G.C. (2014) Engagement of SLAMF2/CD48 Prolongs the Time Frame of Effective T Cell Activation by Supporting Mature Dendritic Cell Survival. The Journal of Immunology, 192, 4436-4442. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Elishmereni, M., Bachelet, I., Nissim Ben-Efraim, A.H., Mankuta, D. and Levi-Schaffer, F. (2013) Interacting Mast Cells and Eosinophils Acquire an Enhanced Activation State in vitro. Allergy, 68, 171-179. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Matsui, T., Connolly, J.E., Michnevitz, M., Chaussabel, D., Yu, C.I., Glaser, C., et al. (2009) CD2 Distinguishes Two Subsets of Human Plasmacytoid Dendritic Cells with Distinct Phenotype and Functions. The Journal of Immunology, 182, 6815-6823. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Evans, E.J., Castro, M.A.A., O’Brien, R., Kearney, A., Walsh, H., Sparks, L.M., et al. (2006) Crystal Structure and Binding Properties of the CD2 and CD244 (2B4)-Binding Protein, CD48. Journal of Biological Chemistry, 281, 29309-19320. [Google Scholar] [CrossRef]
|
|
[32]
|
Dustin, M.L., Sanders, M.E., Shaw, S. and Springer, T.A. (1987) Purified Lymphocyte Function-Associated Antigen 3 Binds to CD2 and Mediates T Lymphocyte Adhesion. Journal of Experimental Medicine, 165, 677-692. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Van Der Merwe, P.A., McPherson, D.C., Brown, M.H., Barclay, A.N., Cyster, J.G., Williams, A.F., et al. (1993) The NH2-Terminal Domain of Rat CD2 Binds Rat CD48 with a Low Affinity and Binding Does not Require Glycosylation of CD2. European Journal of Immunology, 23, 1373-1377. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Li, B., Lu, Y., Zhong, M.C., Qian, J., Li, R., Davidson, D., et al. (2022) cis Interactions between CD2 and Its Ligands on T Cells Are Required for T Cell Activation. Science Immunology, 7, eabn6373. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Qin, L., Chavin, K.D., Lin, J., Yagita, H. and Bromberg, J.S. (1994) Anti-CD2 Receptor and Anti-CD2 Ligand (CD48) Antibodies Synergize to Prolong Allograft Survival. Journal of Experimental Medicine, 179, 341-346. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Whitelock, J.M. and Iozzo, R.V. (2005) Heparan Sulfate: A Complex Polymer Charged with Biological Activity. Chemical Reviews, 105, 2745-2764. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Ianelli, C.J., DeLellis, R. and Thorley-Lawson, D.A. (1998) CD48 Binds to Heparan Sulfate on the Surface of Epithelial Cells. Journal of Biological Chemistry, 273, 23367-23375. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Baorto, D.M., Gao, Z., Malaviya, R., Dustin, M.L., van der Merwe, A., Lublin, D.M., et al. (1997) Survival of FimH-Expressing Enterobacteria in Macrophages Relies on Glycolipid Traffic. Nature, 389, 636-639. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Möller, J., Lühmann, T., Chabria, M., Hall, H. and Vogel, V. (2013) Macrophages Lift off Surface-Bound Bacteria Using a Filopodium-Lamellipodium Hook-and-Shovel Mechanism. Scientific Reports, 3, Article No. 2884. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Muñoz, S., Hernández-Pando, R., Abraham, S.N. and Enciso, J.A. (2003) Mast Cell Activation by Mycobacterium Tuberculosis: Mediator Release and Role of CD48. The Journal of Immunology, 170, 5590-5596. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Gangwar, R.S. and Levi-Schaffer, F. (2016) sCD48 Is Anti-Inflammatory in Staphylococcus Aureus Enterotoxin B-Induced Eosinophilic Inflammation. Allergy, 71, 829-839. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Hamid, Q. and Tulic, M. (2009) Immunobiology of Asthma. Annual Review of Physiology, 71, 489-507. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Ip, W.K., Wong, C.K., Wang, C.B., Tian, Y.P. and Lam, C.W.K. (2005) Interleukin-3,-5, and Granulocyte Macrophage Colony-Stimulating Factor Induce Adhesion and Chemotaxis of Human Eosinophils via p38 Mitogen-Activated Protein Kinase and Nuclear Factor κB. Immunopharmacology and Immunotoxicology, 27, 371-393. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Klaman, L.D. and Thorley-Lawson, D.A. (1995) Characterization of the CD48 Gene Demonstrates a Positive Element that Is Specific to Epstein-Barr Virus-Immortalized B-Cell Lines and Contains an Essential NF-Kappa B Site. Journal of Virology, 69, 871-881. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Ha, S.G., Ge, X.N., Bahaie, N.S., Kang, B.N., Rao, A., Rao, S.P., et al. (2013) ORMDL3 Promotes Eosinophil Trafficking and Activation via Regulation of Integrins and CD48. Nature Communications, 4, Article No. 2479. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Munitz, A., Bachelet, I., Fraenkel, S., Katz, G., Mandelboim, O., Simon, H.U., et al. (2005) 2B4 (CD244) Is Expressed and Functional on Human Eosinophils. The Journal of Immunology, 174, 110-118. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Chen, R., Relouzat, F., Roncagalli, R., Aoukaty, A., Tan, R., Latour, S., et al. (2004) Molecular Dissection of 2B4 Signaling: Implications for Signal Transduction by SLAM-Related Receptors. Molecular and Cellular Biology, 24, 5144-5156. [Google Scholar] [CrossRef]
|
|
[48]
|
Zhang, T., Fang, Q., Liu, P., Wang, P., Feng, C. and Wang, J. (2022) Heme Oxygenase 1 Overexpression Induces Immune Evasion of Acute Myeloid Leukemia against Natural Killer Cells by Inhibiting CD48. Journal of Translational Medicine, 20, Article No. 394. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Siegel, R.L., Miller, K.D., Fuchs, H.E. and Jemal, A. (2021) Cancer Statistics, 2021. CA: A Cancer Journal for Clinicians, 7, 7-33. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Umemoto, T., Johansson, A., Ahmad, S.A.I., Hashimoto, M., Kubota, S., Kikuchi, K., et al. (2022) ATP Citrate Lyase Controls Hematopoietic Stem Cell Fate and Supports Bone Marrow Regeneration. The EMBO Journal, 41, e109463. https://onlinelibrary.wiley.com/doi/10.15252/embj.2021109463 [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Bald, T., Krummel, M.F., Smyth, M.J. and Barry, K.C. (2020) The NK Cell-Cancer Cycle: Advances and New Challenges in NK Cell-Based Immunotherapies. Nature Immunology, 21, 835-847. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
O’Shea, J.J., Holland, S.M. and Staudt, L.M. (2013) JAKs and STATs in Immunity, Immunodeficiency, and Cancer. The New England Journal of Medicine, 368, 161-170. [Google Scholar] [CrossRef]
|
|
[53]
|
Stark, G.R. and Darnell, J.E. (2012) The JAK-STAT Pathway at Twenty. Immunity, 36, 503-514. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Morichika, K., Karube, K., Kayo, H., Uchino, S., Nishi, Y., Nakachi, S., et al. (2019) Phosphorylated STAT 3 Expression Predicts Better Prognosis in Smoldering Type of Adult T-Cell Leukemia/Lymphoma. Cancer Science, 110, 2982-2991. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Maeda, M., Tanabe-Shibuya, J., Miyazato, P., Masutani, H., Yasunaga, J.I, Usami, K., et al. (2020) IL-2/IL-2 Receptor Pathway Plays a Crucial Role in the Growth and Malignant Transformation of HTLV-1-Infected T Cells to Develop Adult T-Cell Leukemia. Frontiers in Microbiology, 11, Article 356. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Keszei, M., Latchman, Y.E., Vanguri, V.K., Brown, D.R., Detre, C., Morra, M., et al. (2011) Auto-Antibody Production and Glomerulonephritis in Congenic Slamf1-/- and Slamf2-/- [B6.129] but not in Slamf1-/- and Slamf2-/- [BALB/c.129] Mice. International Immunology, 23, 149-158. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Koh, A.E., Njoroge, S.W., Feliu, M., Cook, A., Selig, M.K., Latchman, Y.E., et al. (2011) The SLAM Family Member CD48 (Slamf2) Protects Lupus-Prone Mice from Autoimmune Nephritis. Journal of Autoimmunity, 37, 48-57. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Balada, E., Castro-Marrero, J., Pujol, A.P., Torres-Salido, M.T., Vilardell-Tarrés, M. and Ordi-Ros, J. (2011) Enhanced Transcript Levels of CD48 in CD4 T Cells from Systemic Lupus Erythematosus Patients. Immunobiology, 216, 1034-1037. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Karampetsou, M.P., Comte, D., Kis-Toth, K., Kyttaris, V.C. and Tsokos, G.C. (2017) Expression Patterns of Signaling Lymphocytic Activation Molecule Family Members in Peripheral Blood Mononuclear Cell Subsets in Patients with Systemic Lupus Erythematosus. PLOS ONE, 12, e0186073. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Moran, M. and Miceli, M.C. (1998) Engagement of GPI-Linked CD48 Contributes to TCR Signals and Cytoskeletal Reorganization. Immunity, 9, 787-796. [Google Scholar] [CrossRef]
|
|
[61]
|
Krishnan, S., Nambiar, M.P., Warke, V.G., Fisher, C.U., Mitchell, J., Delaney, N., et al. (2004) Alterations in Lipid Raft Composition and Dynamics Contribute to Abnormal T Cell Responses in Systemic Lupus Erythematosus. The Journal of Immunology, 172, 7821-7831. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Abadía-Molina, A.C., Ji, H., Faubion, W.A., Julien, A., Latchman, Y., Yagita, H., et al. (2006) CD48 Controls T-Cell and Antigen-Presenting Cell Functions in Experimental Colitis. Gastroenterology, 130, 424-434. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Luan, H.H., Wang, A., Hilliard, B.K., Carvalho, F., Rosen, C.E., Ahasic, A.M., et al. (2019) GDF15 Is an Inflammation-Induced Central Mediator of Tissue Tolerance. Cell, 178, 1231-1244. E11. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Uhlen, M., Zhang, C., Lee, S., Sjöstedt, E., Fagerberg, L., Bidkhori, G., et al. (2017) A Pathology Atlas of the Human Cancer Transcriptome. Science, 357, eaan2507. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
Wang, Z., He, L., Li, W., Xu, C., Zhang, J., Wang, D., et al. (2021) GDF15 Induces Immunosuppression via CD48 on Regulatory T Cells in Hepatocellular Carcinoma. The Journal for ImmunoTherapy of Cancer, 9, e002787. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Nishikawa, A., Suzuki, K., Kassai, Y., Gotou, Y., Takiguchi, M., Miyazaki, T., et al. (2016) Identification of Definitive Serum Biomarkers Associated with Disease Activity in Primary Sjögren’s Syndrome. Arthritis Research & Therapy, 18, Article 106. [Google Scholar] [CrossRef] [PubMed]
|